Trans-4-hydroxy-lomustine
CAS : 56239-24-8
Ref. 3D-GCA23924
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté |
Informations sur le produit
Nom :
Trans-4-hydroxy-lomustine
Synonymes :
- NSC 239717
- Urea, N-(2-chloroethyl)-N′-(trans-4-hydroxycyclohexyl)-N-nitroso-
- N-(2-Chloroethyl)-N′-(trans-4-hydroxycyclohexyl)-N-nitrosourea
- 1-(2-Chloroethyl)-3-(trans-4-hydroxycyclohexyl)-1-nitrosourea
- Urea, N-(2-chloroethyl)-N′-(4-hydroxycyclohexyl)-N-nitroso-, trans-
Description :
Trans-4-hydroxy-lomustine is a pyridinium salt of the anti-cancer drug lomustine, which is used to treat various types of cancers. It is administered orally and has been shown to have antitumour activity in animal studies. Trans-4-hydroxy-lomustine is metabolized by cytochrome P450 enzymes, including CYP2C8, CYP2C9, and CYP3A4. The major metabolites are monohydroxylated trans-4-hydroxy lomustine, which inhibits DNA synthesis and protein synthesis in cells. This drug also has stereoselective effects on tumor cells compared to normal tissue cells. Trans-4-hydroxy lomustine has high lipophilicity due to its quaternary ammonium group.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
249.69 g/mol
Formule :
C9H16ClN3O3
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
